Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Stentys raises €22.7mm through its initial public offering

Executive Summary

Stentys SA (stents for acute myocardial infarction patients) has raised €22.7mm ($31.9mm) through the initial public offering of 1.9mm shares at €12 each, midway between the company's proposed price range (€10.80-13.20). Stentys' shares will trade on NYSE Euronext Paris.
Deal Industry
  • Medical Devices
  • Pharmaceuticals
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies